ELYSIANT Trademark

Trademark Overview

On Friday, July 7, 2023, a trademark application was filed for ELYSIANT with the United States Patent and Trademark Office. The USPTO has given the ELYSIANT trademark a serial number of 98075181. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Saturday, March 23, 2024. This trademark is owned by UCB Biopharma SRL. The ELYSIANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of neurological diseases
elysiant

General Information

Serial Number98075181
Word MarkELYSIANT
Filing DateFriday, July 7, 2023
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateSaturday, March 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of neurological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code8 - Abandoned
Class Status DateSaturday, March 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB Biopharma SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrussels B-1070
BE
Party NameUCB Biopharma SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrussels B-1070
BE

Trademark Events

Event DateEvent Description
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, March 22, 2024TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, March 23, 2024ABANDONMENT - AFTER PUBLICATION
Thursday, March 7, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 18, 2024ELECTRONIC RECORD REVIEW COMPLETE
Friday, January 12, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, January 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023NON-FINAL ACTION WRITTEN
Monday, November 6, 2023EXAMINER'S AMENDMENT ENTERED
Monday, November 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 1, 2023ASSIGNED TO EXAMINER
Friday, July 21, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, July 21, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, August 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 11, 2023NEW APPLICATION ENTERED

Related Keywords

elysiant neurological diseases treatment substances preparations pharmaceutical